Dose Relation in the Prevention of Proximal Vein Thrombosis with a Low Molecular Weight Heparin (Tinzaparin) in Elective Hip Arthroplasty

Abstract

Keywords

Trial Hip surgery Low molecular weight heparin

References

Prevention of venous thromboembolism. International consensus statement. Int Angiol 1997;16:3-38.

Lassen MR , Borris LC , Christiansen HM , et al. Prevention of thromboembolism in 190 hip arthroplasties. Comparison of LMW heparin and placebo. Acta Orthop Scand 1991;62:33-38.

Rabinov K. , Paulin S. Roentgen diagnosis of venous thrombosis in the leg. Arch Surg 1972;104:134-144.

Zachrisson BE , Jansen H. Phlebographic signs in fresh postoperative venous thrombosis of the lower extremity. Acta Radiol (Diagn) 1973;14:82-96.

Casagrande JT , Pike MC , Smith PG The power function of the exact test for comparing two binominal distributions. Appl Stat 1978 ;27:176-180.

Mätzsch T. , Bergqvist D. , Fredin H. , Hedner U. Safety and efficacy of a low molecular weight heparin (Logiparin) versus dextran as prophylaxis against thrombosis after total hip replacement . Acta Chir Scand 1988;543(suppl):80-84.

Mätzsch T. , Bergqvist D. , Fredin H. , et al. Comparison of the thromboprophylactic effect of low molecular weight heparin versus dextran in total hip replacement. Thromb Haemorrh Disorders 1991; 3:25-29.

Wiman B. , Hamsten A. The fibrinolytic enzyme system and its role in the etiology of thromboembolic disease. Semin Thromb Hemost 1990;16:207-216.

Prentice C.

Thromboprophylaxis in elective orthopaedic surgery— what is the purpose?

J Bone Joint Surg 1997;79;896-899.

10.

Bulstrode Cjk. Commentary on thromboprophylaxis in hip replacement surgery. Acta Orthop Scand 1998;69:343-344.

11.

Planes A. , Vochelle N. , Ferru J. , et al. Enoxaparin low molecular weight heparin its use in the prevention of deep venous thrombosis following total hip replacement. Hemostasis 1986;16:152-158.